<i>SDHB</i> mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma
Julien Hadoux(Université Paris-Saclay), Éric Baudin(Institut Gustave Roussy), C. Chougnet(Université Paris-Sud), Caroline Caramella(Institut Gustave Roussy), Judith Favier(Inserm), Jean‐Yves Scoazec(Université Paris-Saclay), Martin Schlumberger(Université Paris-Saclay), Désirèe Deandreis(Université Paris-Saclay), Rossella Libé(Hôpital Cochin), Isabelle Borget(Inserm), Céline Loriot(Délégation Paris 5), Frédéric Dumont(Institut de Cancérologie de l'Ouest), Laurence Amar(Unit of Functional and Adaptive Biology), Éric Letouzé(Centre National de la Recherche Scientifique), Sophie Leboulleux(Geneva College), Abir Al Ghuzlan(Centre National de la Recherche Scientifique), Jacques Young(Inserm), Anne‐Paule Gimenez‐Roqueplo(Délégation Paris 5), Frédèric Deschamps(Institut Gustave Roussy), Jérôme Bertherat(Centre National de la Recherche Scientifique)
Cited by 207
Related Papers
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
|JAMA Oncology|2016|1.4k
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.3k
The ratio of the nucleon structure functions F2N for iron and deuterium
|Physics Letters B|1983|1.1k
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951